Abstract
Diagnosis of erectile dysfunction (ED) requires anamnestic investigation, being rarely spontaneously declared by patients. ED occurs frequently in diabetes mellitus, and anecdotal evidence suggests that ED occurs in obesity and in hypothyroidism. The aim of this study was to evaluate the prevalence of ED in patients affected by thyroid disorders (hypothyroidism and hyperthyroidism), in comparison with control subjects and with patients at risk for ED, such as patients with obesity and with type II diabetes mellitus, and the role of age. Spontaneous deposition and International Index of Erectile Dysfunction (IIEF)-5 questionnaire were considered for control subjects and for all patients. Spontaneous deposition of ED occurred for three diabetic patients, never for obese patients, thyroid patients and controls, confirming the value of IIEF-5 in detecting ED. ED was more frequent in obese subjects (42%), and in patients affected by thyroid diseases (59%), than in controls (30%), although less frequent than in type II diabetes mellitus (81%). Both below and above the age of 50 years, ED score was worse in thyroid patients than in control subjects, while ED was more frequent in obese patients than in control subjects only below the age of 50 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
NIH Consensus Development Panel on Impotence. NIH consensus conference: impotence. JAMA 1993; 270: 83–90.
Bortolotti A, Perazzini F, Colli E, Landoni M . The epidemiology of erectile dysfunction and its risk factors. Int J Androl 1997; 20: 323–334.
Benet AE, Melman A . The epidemiology of erectile dysfunction. Urol Clin N Am 1995; 22: 699–709.
Mulligan T, Retchin SM, Chinchilli VM, Bettinger CB . The role of aging and chronic disease in sexual dysfunction. J Am Geriatr Soc 1988; 36: 520–524.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachussetts Male Aging Study. J Urol 1994; 151: 54–61.
Mak R, De Baker G, Kornitzer M, De Meyer JM . Prevalence and correlates of erectile dysfunction in a population-based study in Belgium. Eur Urol 2002; 41: 132–138.
Giuliano F, Chevret-Measson M, Tsatsaris A, Reitz C, Murino M, Thonneau P . Prevalence of erectile dysfunction in France: results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 2002; 42: 382–389.
Furlow WL . Prevalence of impotence in the United States. Med Asp Hum Sex 1985; 19: 13–16.
Virag R, Bouilly P, Frydman D . Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 26: 181–184.
Wabrek AJ, Burchell RC . Male sexual dysfunction associated with coronary heart disease. Arch Sex Behav 1980; 9: 69–75.
Bansal S . Sexual dysfunction in hypertensive men. Hypertension 1988; 12: 1–10.
Fedele D, Bortolotti A, Coscelli C, Santeusanio F, Chatenoud L, Colli E et al. Gruppo Italiano Deficit Erettile Diabetici. Erectile dysfunction in type 1 and type 2 diabetics in Italy. Int J Epidemiol 2000; 29: 524–531.
Lue TF . Erectile dysfunction. N Engl J Med 2000; 342: 1802–1813.
McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF . The prevalence of diabetic impotence. Diabetologia 1980; 18: 279–283.
Rubin A, Babbott B . Impotence and diabetes mellitus. JAMA 1958; 168: 498–500.
Brunner GA, Pieber TR, Schattenberg S, Ressi G, Wieselmann G, Altziebler S et al. Erectile dysfunction in patients with type I diabetes mellitus. Wien Med Wochenschr 1995; 145: 584–586.
Klein R, Klein BE, Lee KE, Moss SE, Cruickshanks KJ . Prevalence of self-reported erectile dysfunction in people with long term IDDM. Diabetes Care 1996; 19: 135–141.
Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB . Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol 2000; 163: 460–463.
Fedele D, Coscelli C, Cucinotta D, Forti G, Santeusanio F, Viaggi S et al. Incidence of erectile dysfunction in Italian men with diabetes. J Urol 2001; 166: 1368–1371.
Bancroft J, Wu FC . Changes in erectile responsiveness during androgen replacement therapy. Arch Sex Behav 1983; 12: 59–66.
Buvat J, Lemaire A . Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy. J Urol 1997; 158: 1768–1769.
Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB . Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Int Med 2003; 139: 161–168.
Baskin HJ . Endocrinologic evaluation of impotence. South Med J 1989; 82: 446–449.
Bodie J, Lewis J, Schow D, Monga M . Laboratory evaluation of erectile dysfunction: an evidence based approach. J Urol 2003; 169: 2262–2264.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The international index of erectile dysfunction (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.
Fonseca V, Seftel A, Denne J, Fredlund P . Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia 2004; 47: 1914–1923.
Pontiroli AE, Pizzocri P, Koprivec D, Vedani P, Marchi M, Arcelloni C et al. Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol 2004; 150: 195–200.
Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978–2984.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Veronelli, A., Masu, A., Ranieri, R. et al. Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients. Int J Impot Res 18, 111–114 (2006). https://doi.org/10.1038/sj.ijir.3901364
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901364
Keywords
This article is cited by
-
The global prevalence of sexual dysfunction in men with thyroid gland disorders: a systematic review and meta-analysis
Journal of Diabetes & Metabolic Disorders (2024)
-
Thyroid disorders and male sexual dysfunction
International Journal of Impotence Research (2023)
-
The impact of hyperthyroidism on sexual functions in men and women: a systematic review and meta-analysis
International Journal of Impotence Research (2023)
-
The Role of Hormones in Male Sexual Function
Current Sexual Health Reports (2020)
-
The emerging role of aldosterone/mineralocorticoid receptors in the pathogenesis of erectile dysfunction
Endocrine (2018)